SCHEMBL576151

SCHEMBL576151

C1CCC(SC2CCCC2)C1

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
THRB P10828 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15271208 0.96 ALDH1A1 (0.33) ALDH1A1
SCHEMBL15271001 0.96 ALDH1A1 (0.33) ALDH1A1KMT2A
SCHEMBL22916884 0.96 ALDH1A1 (0.33) ALDH1A1KMT2A
SCHEMBL575824 0.96 ALDH1A1 (0.33) ALDH1A1KMT2A
SCHEMBL22406169 0.96 ALDH1A1 (0.33) ALDH1A1KMT2A
SCHEMBL11665036 0.96 ALDH1A1 (0.33) ALDH1A1KMT2A
SCHEMBL21423699 0.96 ALDH1A1 (0.33) ALDH1A1KMT2A
SCHEMBL22917022 0.96 ALDH1A1 (0.33) ALDH1A1KMT2A
SCHEMBL15270848 0.96 ALDH1A1 (0.33) ALDH1A1KMT2A
SCHEMBL15271064 0.96 ALDH1A1 (0.33) ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2481760-B1 INITIATOR SYSTEM FOR CATIONIC POLYMERIZATION AND POLYMERIZATION METHOD USING SAME CHINA PETROLEUM & CHEM CORP (CN) 2021-05-05 EP claimed
CN-102532368-B Rare earth catalyst and method for polymerizing conjugated diene by using same UNIV BEIJING CHEMICAL 2014-04-02 CN claimed
CN-102532368-A Rare earth catalyst and method for polymerizing conjugated diene by using same UNIV BEIJING CHEMICAL 2012-07-04 CN claimed
US-5578721-A Process for preparation of 3-exomethylene cepham sulfoxide esters LUPIN LABORATORIES LIMITED (IN) 1996-11-26 US claimed
EP-3527593-B1 ISOCYANATE COMPOSITION, METHOD FOR PRODUCING ISOCYANATE COMPOSITION, AND METHOD FOR PRODUCING ISOCYANATE POLYMER ASAHI CHEMICAL IND (JP) 2025-07-23 EP disclosed
EP-3527600-B1 ISOCYANATE COMPOSITION AND PRODUCTION METHOD FOR ISOCYANATE POLYMER ASAHI CHEMICAL IND (JP) 2025-07-09 EP disclosed
US-12100809-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-24 US disclosed
US-20240297344-A1 NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-05 US disclosed
US-20240166649-A1 DIHYDROPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF SHANGHAI VISONPHARMA CO., LTD. (CN) 2024-05-23 US disclosed
WO-2024098856-A1 ANTI-INFLUENZA-VIRUS DERIVATIVES AND USE THEREOF 石家庄迪斯凯威医药科技有限公司 2024-05-16 WO disclosed
WO-2024098273-A1 ANTI-INFLUENZA VIRUS PHOSPHATE ESTER COMPOUND AND USE THEREOF 石家庄迪斯凯威医药科技有限公司 2024-05-16 WO disclosed
CN-117897433-A Episulfide composition, polymerizable composition, cured product, and optical material 三井化学株式会社 2024-04-16 CN disclosed
CN-1014247-B COLLECTION METHOD FOR RECOVERY OF METAL-CONTAINING ORE FROM ORE DOW CHEMICAL CO (US) 1991-10-09 CN disclosed
CN-86101495-A The collector composition that is used for the pneumatic flotation of mineral effective constituent 1987-06-03 CN disclosed
CN-86101682-A Be used for sulfide mineral and select the new collector of pneumatic flotation 1987-01-28 CN disclosed
US-4479964-A CONTRACEPTIVES ORTHO PHARMACEUTICAL CORPORATION (US) 1984-10-30 US disclosed
US-4408060-A UTERO-EVACUANTS ORTHO PHARMACEUTICAL CORPORATION (US) 1983-10-04 US disclosed
US-4176188-A SUBSTITUTED OXEPANE ORTHO PHARMACEUTICAL CORP. (US) 1979-11-27 US disclosed
US-4102895-A Oxepanes ORTHO PHARMACEUTICAL CORPORATION (US) 1978-07-25 US disclosed
US-4052463-A PROCESS FOR PREPARING TERTIARY PHOSPHINE SULFIDES AND OXIDES STAUFFER CHEMICAL COMPANY (US) 1977-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240166649-A1 DIHYDROPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF DPYD, GOT1, WEE1 ALDH1A1 623/4885THRB 4660/4885MEN1 2128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.